Cancer Research UK cuts fundings grants amid pandemic uncertainty
The cuts equate to £44 million, driven by a loss in fundraising income
7th April 2020
-
Driving value from genomics
Hilary Thomas considers the progress and challenges in reaping the benefits of genomics
-
Pitch perfect
A perfect pitch process benefits pharma as much as the agencies involved. Mike Dixon, chief executive of the Healthcare Communications Association, discusses two initiatives trying to help identify best practice guidance for all stakeholders in the pitch process
-
Transformational change
The decade ahead for UK pharma – a shot in the arm or bitter pill to swallow?
News
View all
GSK links with Vir Biotechnology to find coronavirus solutions
GSK has bought a $250 million stake in the firm
7th April 2020
Firms form alliance to work on COVID-19 therapy
The alliance will immediately start work on the development of an unbranded anti-SARS-CoV-2 polyclonal hyperimmune immunoglobulin medicine
7th April 2020
Imophoron develops COVID-19 vaccine candidates
Preclinical testing expected "within weeks"
7th April 2020
Menlo hit with serlopitant setback
Shares in the firm dropped nearly 50% in pre-market trading
7th April 2020
Top trending
-
Gilead starts late-stage trials in the UK of potential COVID-19 therapy
-
COVID-19: NICE updates guideline as Sanofi announces vaccine development
-
Novartis, Incyte to test Jakavi for coronavirus-linked cytokine storm
-
COVID-19: UK commits £210m as pharmacist warns Brits not to stockpile Ventolin inhalers
-
Positive early data from siltuximab COVID-19 trial
-
AbbVie, Allergan megamerger set for May close
Web Exclusives
View all
Six 2020 predictions for real-world evidence
What can we expect to see for real world evidence in 2020 and beyond?
The disproportional economic impact of cancer on women
More than half of women take home less pay after a cancer diagnosis. It is time to talk about the ‘ripple effect’ of a cancer diagnosis, says Pfizer's Dr Olivia Ashman
Rare disease day exclusive
PharmaTimes talks to Biogen's Natalie Ghafoor about her role and views on the rare disease landscape
After February 29
Rare Disease Day is a fixture in the calendar not only for affected patients and families, and patient advocacy organisations, but also the myriad of other stakeholders that make up the rare disease ecosystem
Magazine
View more from the latest edition
Driving value from genomics
Hilary Thomas considers the progress and challenges in reaping the benefits of genomics
Unlocking value
How cell and gene therapies are driving new deals in life sciences
Transformational change
The decade ahead for UK pharma – a shot in the arm or bitter pill to swallow?
A NICE transformation?
Will the NICE Review of Methods and Processes pave the way to HTA reform? As we wait for the consultation, Nicola Boyd argues that we should be realistic about what the Review will deliver
Patient Files: Osteogenesis imperfecta
Ingunn Westerheim shares her experiences of life with a rare bone disorder
A changing landscape
Gustaf Duhs considers the legal issues surrounding the rapidly expanding field of digital health
Smart People: Stephen Nabarro
Stephen Nabarro, head of clinical operations and data management at Cancer Research UK Centre for Drug Development, talks to PharmaTimes about his role in cancer research
Pitch perfect
A perfect pitch process benefits pharma as much as the agencies involved. Mike Dixon, chief executive of the Healthcare Communications Association, discusses two initiatives trying to help identify best practice guidance for all stakeholders in the pitch process
Thought Leadership
View all
Creating common endeavours
Conclusio’s Johnny Skillicorn-Aston and James Roach consider the true meaning of patient-centricity in clinical trials
The Trust Deficit - blockchain toward transparency
Blockchain is quickly moving from interesting pilots to clear use cases as a source of trust
Deep impact
The NHS Long Term Plan and what the industry response should be
The Value Exchange
Simon Grime, of Wilmington Healthcare, explains the principles of exchanging value with customers to gain trust and consent
Webinars
View allDesigning Pharma organisations for success
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
